HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hollingdale, M. R. Articles by Schwartz, A. L. Search for Related Content PubMed PubMed Citation Articles by Hollingdale, M. R. Articles by Schwartz, A. L.

Entry of Plasmodium Berghei Sporozoites into Cultured Cells, and Their Transformation into Trophozoites

Michael R. Hollingdale^*, Pamela Leland^*, James L. Leef^* AND Alan L. Schwartz

^* Biomedical Research Institute, 12111 Parklawn Drive, Rockville, Maryland 20852
Childrens Hospital Medical Center, Boston, Massachusetts 02115

The attachment and entry of Plasmodium berghei sporozoites to cultured human lung fibroblast (WI38) or hepatoma (HepG2-A16) cells in vitro has been visualized using an immunoperoxidase technique coupled with light microscopy. Attachment and entry was substantially more frequent with HepG2-A16 cells, and appeared to be mediated by the Pb44 sporozoite surface protective antigen. When sporozoites were incubated with intact monoclonal antibodies to Pb44 or their monovalent Fab fragments, attachment was inhibited, suggesting that this technique may be an in vitro assay of protective immunity. Sporozoites appeared to enter cells actively, rather than by cell phagocytosis. Once within a membrane-bound vacuole, the sporozoite transformed into a trophozoite. It was suggested that Pb44 recognized a specific cell receptor, and that this technique may permit receptor characterization.

Accepted for publication November 19, 1982.

This article has been cited by other articles:

				K. M. VanBuskirk, M. T. O'Neill, P. De La Vega, A. G. Maier, U. Krzych, J. Williams, M. G. Dowler, J. B. Sacci Jr, N. Kangwanrangsan, T. Tsuboi, et al. Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design PNAS, August 4, 2009; 106(31): 13004 - 13009. [Abstract] [Full Text] [PDF]

				J. SATTABONGKOT, N. YIMAMNUAYCHOKE, S. LEELAUDOMLIPI, M. RASAMEESORAJ, R. JENWITHISUK, R. E. COLEMAN, R. UDOMSANGPETCH, L. CUI, and T. G. BREWER ESTABLISHMENT OF A HUMAN HEPATOCYTE LINE THAT SUPPORTS IN VITRO DEVELOPMENT OF THE EXO-ERYTHROCYTIC STAGES OF THE MALARIA PARASITES PLASMODIUM FALCIPARUM AND P. VIVAX. Am J Trop Med Hyg, May 1, 2006; 74(5): 708 - 715. [Abstract] [Full Text] [PDF]

				K. Kaiser, N. Camargo, and S. H.I. Kappe Transformation of Sporozoites into Early Exoerythrocytic Malaria Parasites Does Not Require Host Cells J. Exp. Med., April 21, 2003; 197(8): 1045 - 1050. [Abstract] [Full Text] [PDF]

				J. Sadoff, W. Ballou, L. Baron, W. Majarian, R. Brey, W. Hockmeyer, J. Young, S. Cryz, J Ou, G. Lowell, et al. Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria Science, April 15, 1988; 240(4850): 336 - 338. [Abstract] [PDF]

				J. Egan, J. Weber, W. Ballou, M. Hollingdale, W. Majarian, D. Gordon, W. Maloy, S. Hoffman, R. Wirtz, I Schneider, et al. Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development Science, April 24, 1987; 236(4800): 453 - 456. [Abstract] [PDF]

				A Ferreira, L Schofield, V Enea, H Schellekens, P van der Meide, W. Collins, R. Nussenzweig, and V Nussenzweig Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon Science, May 16, 1986; 232(4752): 881 - 884. [Abstract] [PDF]